Global Human Induced Pluripotent Stem Cells (iPSCs) Market Growth (Status and Outlook) 2026-2032
The global Human Induced Pluripotent Stem Cells (iPSCs) market size is predicted to grow from US$ 153 million in 2025 to US$ 501 million in 2032; it is expected to grow at a CAGR of 18.9% from 2026 to 2032.
Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.
United States market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Induced Pluripotent Stem Cells (iPSCs) players cover FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Human Induced Pluripotent Stem Cells (iPSCs) Industry Forecast? looks at past sales and reviews total world Human Induced Pluripotent Stem Cells (iPSCs) sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Induced Pluripotent Stem Cells (iPSCs) sales for 2026 through 2032. With Human Induced Pluripotent Stem Cells (iPSCs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Induced Pluripotent Stem Cells (iPSCs) industry.
This Insight Report provides a comprehensive analysis of the global Human Induced Pluripotent Stem Cells (iPSCs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Induced Pluripotent Stem Cells (iPSCs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Induced Pluripotent Stem Cells (iPSCs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Induced Pluripotent Stem Cells (iPSCs) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Induced Pluripotent Stem Cells (iPSCs).
This report presents a comprehensive overview, market shares, and growth opportunities of Human Induced Pluripotent Stem Cells (iPSCs) market by product type, application, key players and key regions and countries.
Segmentation by Type:
Induced pluripotent stem cells (iPSCs) are genetically reprogrammed adult cells that exhibit a pluripotent stem cell-like state similar to embryonic stem cells.1 While these artificially generated cells are not known to exist in the human body, they show qualities remarkably similar to those of embryonic stem cells (ESCs); thus, iPSCs are an invaluable resource for drug discovery, cell therapy, and basic research.
United States market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Human Induced Pluripotent Stem Cells (iPSCs) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Human Induced Pluripotent Stem Cells (iPSCs) players cover FUJIFILM Cellular Dynamics, Takara Bio, Thermo Fisher Scientific, Ncardia, Sumitomo Dainippon Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Human Induced Pluripotent Stem Cells (iPSCs) Industry Forecast? looks at past sales and reviews total world Human Induced Pluripotent Stem Cells (iPSCs) sales in 2025, providing a comprehensive analysis by region and market sector of projected Human Induced Pluripotent Stem Cells (iPSCs) sales for 2026 through 2032. With Human Induced Pluripotent Stem Cells (iPSCs) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Induced Pluripotent Stem Cells (iPSCs) industry.
This Insight Report provides a comprehensive analysis of the global Human Induced Pluripotent Stem Cells (iPSCs) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Induced Pluripotent Stem Cells (iPSCs) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Human Induced Pluripotent Stem Cells (iPSCs) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Induced Pluripotent Stem Cells (iPSCs) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Induced Pluripotent Stem Cells (iPSCs).
This report presents a comprehensive overview, market shares, and growth opportunities of Human Induced Pluripotent Stem Cells (iPSCs) market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Skin
- Blood
- Others
- Academic Research
- Drug Development and Discovery
- Toxicity Screening
- Regenerative Medicine
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- FUJIFILM Cellular Dynamics
- Takara Bio
- Thermo Fisher Scientific
- Ncardia
- Sumitomo Dainippon Pharma
- Astellas Pharma
- Fate Therapeutics
- Cell Inspire Biotechnology
- ReproCELL
- AcceGen
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
2.1.2 Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Human Induced Pluripotent Stem Cells (iPSCs) by Country/Region (2021, 2025 & 2032)
2.2 Human Induced Pluripotent Stem Cells (iPSCs) Segment by Type
2.2.1 Skin
2.2.2 Blood
2.2.3 Others
2.2.4 Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
2.2.4.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
2.3 Human Induced Pluripotent Stem Cells (iPSCs) Segment by Application
2.3.1 Academic Research
2.3.2 Drug Development and Discovery
2.3.3 Toxicity Screening
2.3.4 Regenerative Medicine
2.3.5 Others
2.3.6 Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
2.3.6.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
3 HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SIZE BY PLAYER
3.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Player
3.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Player (2021-2026)
3.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2021-2026)
3.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS) BY REGION
4.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026)
4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
4.4 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
4.5 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
5.2 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
5.3 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026)
6.2 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
6.3 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
7.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
7.3 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) by Region (2021-2026)
8.2 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET FORECAST
10.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.1.2 Americas Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.3 APAC Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.5 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2 Americas Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2027-2032)
10.2.1 United States Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2.2 Canada Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2.3 Mexico Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2.4 Brazil Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3 APAC Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.3.1 China Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.2 Japan Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.3 Korea Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.4 Southeast Asia Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.5 India Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.6 Australia Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2027-2032)
10.4.1 Germany Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.2 France Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.3 UK Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.4 Italy Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.5 Russia Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.5.1 Egypt Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5.2 South Africa Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5.3 Israel Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5.4 Turkey Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.6 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Type (2027-2032)
10.7 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
11 KEY PLAYERS ANALYSIS
11.1 FUJIFILM Cellular Dynamics
11.1.1 FUJIFILM Cellular Dynamics Company Information
11.1.2 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.1.3 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 FUJIFILM Cellular Dynamics Main Business Overview
11.1.5 FUJIFILM Cellular Dynamics Latest Developments
11.2 Takara Bio
11.2.1 Takara Bio Company Information
11.2.2 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.2.3 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Takara Bio Main Business Overview
11.2.5 Takara Bio Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.3.3 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Ncardia
11.4.1 Ncardia Company Information
11.4.2 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.4.3 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Ncardia Main Business Overview
11.4.5 Ncardia Latest Developments
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Company Information
11.5.2 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.5.3 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sumitomo Dainippon Pharma Main Business Overview
11.5.5 Sumitomo Dainippon Pharma Latest Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Information
11.6.2 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.6.3 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Astellas Pharma Main Business Overview
11.6.5 Astellas Pharma Latest Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Information
11.7.2 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.7.3 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Fate Therapeutics Main Business Overview
11.7.5 Fate Therapeutics Latest Developments
11.8 Cell Inspire Biotechnology
11.8.1 Cell Inspire Biotechnology Company Information
11.8.2 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.8.3 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cell Inspire Biotechnology Main Business Overview
11.8.5 Cell Inspire Biotechnology Latest Developments
11.9 ReproCELL
11.9.1 ReproCELL Company Information
11.9.2 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.9.3 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ReproCELL Main Business Overview
11.9.5 ReproCELL Latest Developments
11.10 AcceGen
11.10.1 AcceGen Company Information
11.10.2 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.10.3 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AcceGen Main Business Overview
11.10.5 AcceGen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
2.1.2 Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Human Induced Pluripotent Stem Cells (iPSCs) by Country/Region (2021, 2025 & 2032)
2.2 Human Induced Pluripotent Stem Cells (iPSCs) Segment by Type
2.2.1 Skin
2.2.2 Blood
2.2.3 Others
2.2.4 Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
2.2.4.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
2.3 Human Induced Pluripotent Stem Cells (iPSCs) Segment by Application
2.3.1 Academic Research
2.3.2 Drug Development and Discovery
2.3.3 Toxicity Screening
2.3.4 Regenerative Medicine
2.3.5 Others
2.3.6 Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
2.3.6.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.6.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
3 HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET SIZE BY PLAYER
3.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Player
3.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Player (2021-2026)
3.1.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2021-2026)
3.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS) BY REGION
4.1 Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026)
4.2 Global Human Induced Pluripotent Stem Cells (iPSCs) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
4.4 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
4.5 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
4.6 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
5.2 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
5.3 Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026)
6.2 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
6.3 APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
7.2 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
7.3 Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) by Region (2021-2026)
8.2 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
8.3 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HUMAN INDUCED PLURIPOTENT STEM CELLS (IPSCS) MARKET FORECAST
10.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.1.1 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.1.2 Americas Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.3 APAC Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.1.5 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2 Americas Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2027-2032)
10.2.1 United States Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2.2 Canada Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2.3 Mexico Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.2.4 Brazil Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3 APAC Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.3.1 China Human Induced Pluripotent Stem Cells (iPSCs) Market Forecast
10.3.2 Japan Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.3 Korea Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.4 Southeast Asia Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.5 India Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.3.6 Australia Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4 Europe Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Country (2027-2032)
10.4.1 Germany Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.2 France Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.3 UK Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.4 Italy Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.4.5 Russia Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5 Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Region (2027-2032)
10.5.1 Egypt Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5.2 South Africa Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5.3 Israel Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.5.4 Turkey Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
10.6 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Type (2027-2032)
10.7 Global Human Induced Pluripotent Stem Cells (iPSCs) Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Human Induced Pluripotent Stem Cells (iPSCs) Forecast
11 KEY PLAYERS ANALYSIS
11.1 FUJIFILM Cellular Dynamics
11.1.1 FUJIFILM Cellular Dynamics Company Information
11.1.2 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.1.3 FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 FUJIFILM Cellular Dynamics Main Business Overview
11.1.5 FUJIFILM Cellular Dynamics Latest Developments
11.2 Takara Bio
11.2.1 Takara Bio Company Information
11.2.2 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.2.3 Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Takara Bio Main Business Overview
11.2.5 Takara Bio Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.3.3 Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Ncardia
11.4.1 Ncardia Company Information
11.4.2 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.4.3 Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Ncardia Main Business Overview
11.4.5 Ncardia Latest Developments
11.5 Sumitomo Dainippon Pharma
11.5.1 Sumitomo Dainippon Pharma Company Information
11.5.2 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.5.3 Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sumitomo Dainippon Pharma Main Business Overview
11.5.5 Sumitomo Dainippon Pharma Latest Developments
11.6 Astellas Pharma
11.6.1 Astellas Pharma Company Information
11.6.2 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.6.3 Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Astellas Pharma Main Business Overview
11.6.5 Astellas Pharma Latest Developments
11.7 Fate Therapeutics
11.7.1 Fate Therapeutics Company Information
11.7.2 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.7.3 Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Fate Therapeutics Main Business Overview
11.7.5 Fate Therapeutics Latest Developments
11.8 Cell Inspire Biotechnology
11.8.1 Cell Inspire Biotechnology Company Information
11.8.2 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.8.3 Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cell Inspire Biotechnology Main Business Overview
11.8.5 Cell Inspire Biotechnology Latest Developments
11.9 ReproCELL
11.9.1 ReproCELL Company Information
11.9.2 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.9.3 ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ReproCELL Main Business Overview
11.9.5 ReproCELL Latest Developments
11.10 AcceGen
11.10.1 AcceGen Company Information
11.10.2 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
11.10.3 AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 AcceGen Main Business Overview
11.10.5 AcceGen Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Induced Pluripotent Stem Cells (iPSCs) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Skin
Table 4. Major Players of Blood
Table 5. Major Players of Others
Table 6. Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Table 9. Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Table 12. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2021-2026)
Table 14. Human Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
Table 15. Human Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Table 20. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2021-2026)
Table 24. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Table 26. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Table 28. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Table 30. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2021-2026)
Table 34. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Human Induced Pluripotent Stem Cells (iPSCs)
Table 40. Key Market Challenges & Risks of Human Induced Pluripotent Stem Cells (iPSCs)
Table 41. Key Industry Trends of Human Induced Pluripotent Stem Cells (iPSCs)
Table 42. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. FUJIFILM Cellular Dynamics Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 47. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 48. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. FUJIFILM Cellular Dynamics Main Business
Table 50. FUJIFILM Cellular Dynamics Latest Developments
Table 51. Takara Bio Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 52. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 53. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Takara Bio Main Business
Table 55. Takara Bio Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 58. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Thermo Fisher Scientific Main Business
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Ncardia Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 62. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 63. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Ncardia Main Business
Table 65. Ncardia Latest Developments
Table 66. Sumitomo Dainippon Pharma Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 67. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 68. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sumitomo Dainippon Pharma Main Business
Table 70. Sumitomo Dainippon Pharma Latest Developments
Table 71. Astellas Pharma Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 72. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 73. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Astellas Pharma Main Business
Table 75. Astellas Pharma Latest Developments
Table 76. Fate Therapeutics Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 77. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 78. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Fate Therapeutics Main Business
Table 80. Fate Therapeutics Latest Developments
Table 81. Cell Inspire Biotechnology Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 82. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 83. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Cell Inspire Biotechnology Main Business
Table 85. Cell Inspire Biotechnology Latest Developments
Table 86. ReproCELL Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 87. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 88. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. ReproCELL Main Business
Table 90. ReproCELL Latest Developments
Table 91. AcceGen Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 92. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 93. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. AcceGen Main Business
Table 95. AcceGen Latest Developments
Table 1. Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Human Induced Pluripotent Stem Cells (iPSCs) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Skin
Table 4. Major Players of Blood
Table 5. Major Players of Others
Table 6. Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Table 9. Human Induced Pluripotent Stem Cells (iPSCs) Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Table 12. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player (2021-2026)
Table 14. Human Induced Pluripotent Stem Cells (iPSCs) Key Players Head office and Products Offered
Table 15. Human Induced Pluripotent Stem Cells (iPSCs) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Table 20. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2021-2026)
Table 24. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Table 26. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Table 28. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Table 30. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country (2021-2026)
Table 34. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Human Induced Pluripotent Stem Cells (iPSCs)
Table 40. Key Market Challenges & Risks of Human Induced Pluripotent Stem Cells (iPSCs)
Table 41. Key Industry Trends of Human Induced Pluripotent Stem Cells (iPSCs)
Table 42. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. FUJIFILM Cellular Dynamics Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 47. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 48. FUJIFILM Cellular Dynamics Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. FUJIFILM Cellular Dynamics Main Business
Table 50. FUJIFILM Cellular Dynamics Latest Developments
Table 51. Takara Bio Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 52. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 53. Takara Bio Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Takara Bio Main Business
Table 55. Takara Bio Latest Developments
Table 56. Thermo Fisher Scientific Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 57. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 58. Thermo Fisher Scientific Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Thermo Fisher Scientific Main Business
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Ncardia Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 62. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 63. Ncardia Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Ncardia Main Business
Table 65. Ncardia Latest Developments
Table 66. Sumitomo Dainippon Pharma Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 67. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 68. Sumitomo Dainippon Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sumitomo Dainippon Pharma Main Business
Table 70. Sumitomo Dainippon Pharma Latest Developments
Table 71. Astellas Pharma Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 72. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 73. Astellas Pharma Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Astellas Pharma Main Business
Table 75. Astellas Pharma Latest Developments
Table 76. Fate Therapeutics Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 77. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 78. Fate Therapeutics Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Fate Therapeutics Main Business
Table 80. Fate Therapeutics Latest Developments
Table 81. Cell Inspire Biotechnology Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 82. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 83. Cell Inspire Biotechnology Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Cell Inspire Biotechnology Main Business
Table 85. Cell Inspire Biotechnology Latest Developments
Table 86. ReproCELL Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 87. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 88. ReproCELL Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. ReproCELL Main Business
Table 90. ReproCELL Latest Developments
Table 91. AcceGen Details, Company Type, Human Induced Pluripotent Stem Cells (iPSCs) Area Served and Its Competitors
Table 92. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Product Offered
Table 93. AcceGen Human Induced Pluripotent Stem Cells (iPSCs) Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. AcceGen Main Business
Table 95. AcceGen Latest Developments
LIST OF FIGURES
Figure 1. Human Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Induced Pluripotent Stem Cells (iPSCs) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2025)
Figure 8. Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2025
Figure 10. Human Induced Pluripotent Stem Cells (iPSCs) in Academic Research
Figure 11. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2021-2026) & ($ millions)
Figure 12. Human Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery
Figure 13. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2021-2026) & ($ millions)
Figure 14. Human Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening
Figure 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2021-2026) & ($ millions)
Figure 16. Human Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine
Figure 17. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2021-2026) & ($ millions)
Figure 18. Human Induced Pluripotent Stem Cells (iPSCs) in Others
Figure 19. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Others (2021-2026) & ($ millions)
Figure 20. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2025
Figure 21. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2025
Figure 22. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Figure 23. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 24. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 25. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 27. Americas Human Induced Pluripotent Stem Cells (iPSCs) Value Market Share by Country in 2025
Figure 28. United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2025
Figure 33. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Figure 34. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Figure 35. China Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 39. India Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2025
Figure 42. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Figure 43. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Figure 44. Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 45. France Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 58. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 59. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 61. United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 62. Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 63. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 64. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 65. China Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 66. Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 67. Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 69. India Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 70. Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 71. Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 72. France Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 73. UK Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 74. Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 75. Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 76. Egypt Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 77. South Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 78. Israel Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 79. Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 80. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 1. Human Induced Pluripotent Stem Cells (iPSCs) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Human Induced Pluripotent Stem Cells (iPSCs) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2025)
Figure 8. Human Induced Pluripotent Stem Cells (iPSCs) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type in 2025
Figure 10. Human Induced Pluripotent Stem Cells (iPSCs) in Academic Research
Figure 11. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Academic Research (2021-2026) & ($ millions)
Figure 12. Human Induced Pluripotent Stem Cells (iPSCs) in Drug Development and Discovery
Figure 13. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Drug Development and Discovery (2021-2026) & ($ millions)
Figure 14. Human Induced Pluripotent Stem Cells (iPSCs) in Toxicity Screening
Figure 15. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Toxicity Screening (2021-2026) & ($ millions)
Figure 16. Human Induced Pluripotent Stem Cells (iPSCs) in Regenerative Medicine
Figure 17. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Regenerative Medicine (2021-2026) & ($ millions)
Figure 18. Human Induced Pluripotent Stem Cells (iPSCs) in Others
Figure 19. Global Human Induced Pluripotent Stem Cells (iPSCs) Market: Others (2021-2026) & ($ millions)
Figure 20. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application in 2025
Figure 21. Global Human Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Player in 2025
Figure 22. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Figure 23. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 24. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 25. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2021-2026 ($ millions)
Figure 27. Americas Human Induced Pluripotent Stem Cells (iPSCs) Value Market Share by Country in 2025
Figure 28. United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region in 2025
Figure 33. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Figure 34. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Figure 35. China Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 39. India Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Country in 2025
Figure 42. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Figure 43. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Figure 44. Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 45. France Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Human Induced Pluripotent Stem Cells (iPSCs) Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 58. APAC Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 59. Europe Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 61. United States Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 62. Canada Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 63. Mexico Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 64. Brazil Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 65. China Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 66. Japan Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 67. Korea Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 69. India Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 70. Australia Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 71. Germany Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 72. France Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 73. UK Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 74. Italy Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 75. Russia Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 76. Egypt Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 77. South Africa Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 78. Israel Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 79. Turkey Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
Figure 80. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Human Induced Pluripotent Stem Cells (iPSCs) Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Human Induced Pluripotent Stem Cells (iPSCs) Market Size 2027-2032 ($ millions)
